EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ductal carcinoma in situ of the breasts: Over‐diagnosis, over‐treatment and a decade of lost direction

Michael Co

Precision Medical Sciences · 2020

DOI: 10.1002/prm2.12008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Precision Medical Sciences, 2020. Verfasst von Michael Co. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ductal carcinoma in situ (DCIS) of the breast is the earliest detectable form of breast cancer. Mainstay of treatment is complete surgical removal with or without adjuvant radiotherapy. Incidence of DCIS has increased significantly over the last decade; however, increased surgical removal of DCIS has not resulted in the decreased incidence of invasive breast cancer. Whether or not we are over‐treating ductal carcinoma in situ (DCIS) with complete surgical removal of the tumor has been subjected to much debate.

Zitieren

APA

Co, M. (2020). Ductal carcinoma in situ of the breasts: Over‐diagnosis, over‐treatment and a decade of lost direction. Precision Medical Sciences. https://doi.org/10.1002/prm2.12008

Vancouver

Co M. Ductal carcinoma in situ of the breasts: Over‐diagnosis, over‐treatment and a decade of lost direction. Precision Medical Sciences. 2020. doi:10.1002/prm2.12008

BibTeX
@article{Co2020,
  author = {Co, Michael},
  title = {Ductal carcinoma in situ of the breasts: Over‐diagnosis, over‐treatment and a decade of lost direction},
  journal = {Precision Medical Sciences},
  year = {2020},
  doi = {10.1002/prm2.12008}
}
Kostenlos starten →